SREBF1功能获得性变异导致泛发性皮肤色素沉着伴先天性白内障
研究通过全外显子组测序在两名无关患者中鉴定出SREBF1新发无义变异c.1289C>A(p.Ser430*),该变异编码的截短蛋白优先定位于细胞核并具有增强的转录活性。患者原代黑素细胞黑色素合成增加,转基因斑马鱼模型出现更多黑斑及黑色素生成基因上调,表明SREBF1功能获得性变异导致以泛发性皮肤色素沉着和先天性白内障为特征的新疾病。
要点
- SREBF1 p.Ser430*功能获得性变异可导致泛发性皮肤色素沉着伴先天性白内障。
- 该变异蛋白优先核定位且转录活性增强,患者黑素细胞黑色素合成增加。
- 斑马鱼模型验证该变异促进黑色素生成,提示SREBP-1参与黑素生成与晶状体发育。
核心结论
- SREBF1功能获得性变异导致一种以泛发性皮肤色素沉着和先天性白内障为特征的新疾病。
研究设计与样本
- 研究对两名表现为泛发性皮肤色素沉着伴先天性白内障的患者进行全外显子组测序。
- 采用定量PCR、Western blot和免疫荧光评估变异蛋白表达与亚细胞定位。
- 通过荧光素酶报告基因检测突变体转录活性,并构建转基因斑马鱼模型。
主要发现
- 两名无关患者均携带SREBF1新发无义变异c.1289C>A(p.Ser430*)。
- 突变蛋白优先定位于细胞核,而野生型SREBP-1在甾醇充足条件下主要位于细胞质。
- 荧光素酶报告基因检测显示p.Ser430*突变体转录活性增强。
- 患者原代黑素细胞较健康对照黑色素合成增加。
- 受精后35天,p.Ser430*转基因斑马鱼模型显示更多黑斑,且黑色素生成基因表达上调。
临床怎么用
- 对泛发性皮肤色素沉着伴先天性白内障的患者,可考虑SREBF1基因检测以明确遗传病因。
- SREBP-1可能成为皮肤色素异常或白内障的新治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lipid metabolism has essential roles in skin barrier formation and the regulation of skin inflammation. Lipid homeostasis regulates skin melanogenesis, although the underlying mechanism remains largely unknown. Sterol regulatory element binding protein 1 (SREBP-1) is a key transcription factor essential for cellular lipid metabolism. Loss-of-function variants in SREBF1 are responsible for autosomal-dominant ichthyosis follicularis, alopecia and photophobia syndrome, emphasizing the significance of lipid homeostasis in skin keratinization. OBJECTIVES: To identify the genetic basis of a new entity featuring diffuse skin hyperpigmentation with congenital cataracts, and to unravel the underlying mechanism for the pathogenesis of the SREBF1 variant. METHODS: Whole-exome sequencing was performed to identify underlying genetic variants. Quantitative polymerase chain reaction, Western blot and immunofluorescence staining were used to assess the expression and the subcellular localization of the SREBF1 variant. The transcriptional activity of mutant SREBP-1 was determined by a luciferase reporter assay. A transgenic zebrafish model was constructed. RESULTS: Two unrelated patients presented with generalized skin hyperpigmentation with skin xerosis, congenital cataracts and extracutaneous symptoms. We identified a de novo nonsense variant c.1289C>A (p.Ser430*) in SREBF1 in both patients. The variant encoded a truncated protein that showed preferential nucleus localization, in contrast to wild-type SREBP-1 which - in sterol-sufficient conditions - is mainly localized in the cytoplasm. The luciferase reporter assay revealed that the p.Ser430* mutant exhibited enhanced transcriptional activity. Cultured patient primary melanocytes showed increased melanin synthesis vs. those from healthy controls. At 35 days postfertilization, the p.Ser430* transgenic zebrafish model exhibited more black spots, along with upregulated expression of melanogenic genes. CONCLUSIONS: We demonstrated that a gain-of-function variant of SREBF1 causes a previously undescribed disorder characterized by generalized skin hyperpigmentation and congenital cataracts. Our study reveals the involvement of SREBP-1 in melanogenesis and lens development, and paves the way for the development of novel therapeutic targets for skin dyspigmentation or cataracts. The genetic basis of many diseases that cause skin hyperpigmentation are not fully understood. Hyperpigmentation means that some patches of skin are darker than others. This is caused by the overproduction of a pigment called melanin. We report on two patients who were born with skin hyperpigmentation and cataracts. The cause of the patients’ disease was unknown, so we carried out genetic testing in the patients. The tests showed that both patients had a change (‘mutation’) in a gene called ‘SREBF1’. This gene encodes for a protein called SREBF-1. Other mutations in this protein are involved in other skin diseases. A different test showed that the mutated SREBF1 gene was activated more often than normal. Skin cells taken from both patients also produced more pigment than cells taken from people without hyperpigmentation. To confirm this gene mutation causes more skin pigmentation, we did an experiment with zebrafish with the same mutation. At 35 days after fertilization, the zebrafish showed more black spots on their skin. Our study reveals the involvement of SREBP-1 in the production of melanin and lens development in the eye. The findings may offer a new approach to treating hyperpigmentation in skin diseases.
引用
- Wang H, Wu Y, Bassetti JA, et al. A gain-of-function variant in SREBF1 causes generalized skin hyperpigmentation with congenital cataracts. Br J Dermatol. 2024. PMID: 39005171. doi:10.1093/bjd/ljae291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。